翻訳と辞書 Words near each other ・ Intersalt study ・ Interscholastic ・ Interscholastic Association of Southeast Asian Schools ・ Interscholastic Athletic Association of Maryland ・ Interscholastic Hockey League ・ Interscholastic League of Honolulu ・ Interscholastic Sailing Association ・ InterSchool Orchestras of New York ・ Interscience Institute of Management & Technology ・ Interscope Communications ・ Interscope Geffen A&M Records ・ Interscope Records ・ Interscope Records discography ・ Intersec ・ Intersect (video game) ・ Intersect ENT ・ Intersecting Storage Rings ・ Intersection ・ Intersection (1994 film) ・ Intersection (aeronautics) ・ Intersection (album) ・ Intersection (disambiguation) ・ Intersection (Euclidean geometry) ・ Intersection (novel) ・ Intersection (road) ・ Intersection (sculpture) ・ Intersection (set theory) ・ Intersection algorithm ・ Intersection assistant ・ Intersection capacity utilization Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Intersect ENT ： ウィキペディア英語版 Intersect ENT Intersect ENT () is a publicly traded health care equipment company based in Menlo Park, California.〔 It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Intersect ENT is best known for developing the first bioabsorbable drug-eluting sinus stent PROPEL, which delivers anti-inflammatory medication directly to the sinuses. The company holds over 20 issued patents in the United States and more than 80 patents and patent applications worldwide. The company was named on the Forbes list of ''America's Most Promising Companies'' and was also on the ''Firece 15'' list of ''Most Promising Companies'' in 2013. ==History== Intersect ENT was founded in 2003 by Don Eaton who conceived of the product over dinner with ENT surgeon, Mary Lynn Moran, MD.〔 The company received its Series A funding in 2006, prompting the hiring of a team to develop the product.〔 It was originally headquartered in Palo Alto, California, then moved to Menlo Park, CA in April 2012 to a new 32,000-foot facility.〔 The facility houses all of its business and manufacturing operations. Prior to the company becoming public, venture capital investors in the company include medical device company Medtronic Inc. and venture capital firms Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Norwest Venture Partners. In 2013 it received $30 million in a series D round of financing led by Norwest Venture Partners, and included all named investors.〔 Intersect ENT announced that the funding would be used for commercial expansion of its PROPEL and PROPEL mini devices, as well as clinical studies for additional devices manufactured to add to the company's portfolio of drug-delivery products.〔 In 2014, Intersect ENT went public on the NASDAQ with an offering of 5,750,000 shares of common stock. It began officially trading on July 24, 2014. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Intersect ENT」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.